Cite
P3-073: Clinical predictor of response to gefitinib in Thai patients with non-small cell lung cancer
MLA
Sumitra Thongprasert, et al. “P3-073: Clinical Predictor of Response to Gefitinib in Thai Patients with Non-Small Cell Lung Cancer.” Journal of Thoracic Oncology, vol. 2, Aug. 2007, p. S709. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....923fa0858633a873ed78ee16a0e1a5f4&authtype=sso&custid=ns315887.
APA
Sumitra Thongprasert, Chaiyut Charoentum, Busayamas Chewasakulyong, & Suthirak Munprakarn. (2007). P3-073: Clinical predictor of response to gefitinib in Thai patients with non-small cell lung cancer. Journal of Thoracic Oncology, 2, S709.
Chicago
Sumitra Thongprasert, Chaiyut Charoentum, Busayamas Chewasakulyong, and Suthirak Munprakarn. 2007. “P3-073: Clinical Predictor of Response to Gefitinib in Thai Patients with Non-Small Cell Lung Cancer.” Journal of Thoracic Oncology 2 (August): S709. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....923fa0858633a873ed78ee16a0e1a5f4&authtype=sso&custid=ns315887.